Salicylic acid derivatives as simplified and novel GK small molecule activators
Lian-Chao HUO; Yu-Liang ZHANG; Lei LEI; Shuai-Nan LIU; Zhu-Fang SHEN; Yu-Ling WANG; Hong-Rui SONG; Zhi-Qiang FENG.
Acta Pharmaceutica Sinica
; (12): 514-520, 2013.
ArtÃculo en Zh | WPRIM | ID: wpr-235635
Documentos relacionados
[Salicylic acid derivatives as simplified and novel GK small molecule activators].
Systems Immunology Approaches to Metabolism.
Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator.
Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes.
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Identification of a new class of glucokinase activators through structure-based design.
Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia.
A comprehensive review on glucokinase activators: Promising agents for the treatment of Type 2 diabetes.
(Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators.
Visiblelight-induced ternary electron donor-acceptor complex enabled synthesis of 2-(2-hydrazinyl) thiazole derivatives and the assessment of their antioxidant and antidiabetic therapeutic potential.